Special Issue "Anti-Infective Agents"


A special issue of Pharmaceuticals (ISSN 1424-8247).

Deadline for manuscript submissions: closed (31 March 2010)

Special Issue Editors

Guest Editor
Prof. Dr. Mark Hamann
Department of Pharmacognosy and The National Center for the Development of Natural Products, University of Mississippi, USA
Website: http://www.pharmacy.olemiss.edu/pharmacognosy/Hamann/Hamannres.html
E-Mail: mthamann@olemiss.edu
Interests: natural products; antiinfectives; anticancer agents; NMR spectroscopy; marine ecology; synthesis of natural products; biosynthesis

Guest Editor
Prof. Dr. Paul Cos
Laboratory of Microbiology, Parasitology and Hygiene (LMPH), Department of Pharmaceutical Sciences, Faculty of Pharmaceutical, Biomedical and Veterinary Sciences Antwerp University, campus drie eiken, building S, office 7.26 Universiteitsplein 1, B-2610 Antwerp, Belgium
Website: http://www.ua.ac.be/paul.cos
E-Mail: paul.cos@ua.ac.be
Interests: anti-infective agents; biofilm; bacterial virulence; oxidative stress; antibacterial; antifungal; antiparasitic and antiviral

Special Issue Information

Dear Colleagues,

Despite the tremendous progress in human medicine, infectious diseases represent one of the greatest challenges to mankind in the 21st century. According to WHO, infectious diseases account for nearly a third of global deaths. AIDS, malaria, tuberculosis and respiratory infections were among the top eight leading causes of death in 2004. The burden of infectious diseases falls particularly on the less developed countries due to the relative unavailability of medicines and the emergence of widespread drug resistance. In developing countries, a high infectious disease burden commonly co-exists with rapid emergence and spread of microbial resistance. The growing threat of emerging diseases such as SARS and influenza A (H1N1) has served as a wake-up call to public health services, pharmaceutical industry and academia.
Because the evolution of drug resistance is likely to compromise every drug in time, research on new anti-infective agents must be continued and all possible strategies should be explored. Besides small molecules from medicinal chemistry, natural products are still major sources of innovative therapeutic agents for various conditions, including infectious diseases.
This special issue welcomes research articles and comprehensive reviews addressing the discovery and/or development of anti-infective agents.

Prof. Dr. Paul Cos
Prof. Dr. Mark Hamann
Guest Editor


  • anti-infectives
  • biofilm
  • bacterial virulence
  • oxidative stress
  • antibacterial
  • antifungal
  • antiparasitic
  • antiviral
  • screening
  • small molecules
  • natural products

Related Special Issue

Published Papers (4 papers)

by ,  and
Pharmaceuticals 2011, 4(1), 169-186; doi:10.3390/ph4010169
Received: 14 December 2010; in revised form: 22 December 2010 / Accepted: 5 January 2011 / Published: 11 January 2011
Show/Hide Abstract | Cited by 6 | PDF Full-text (194 KB) | HTML Full-text | XML Full-text

by , , , , ,  and
Pharmaceuticals 2010, 3(9), 2900-2909; doi:10.3390/ph3092900
Received: 15 May 2010; in revised form: 6 July 2010 / Accepted: 14 July 2010 / Published: 1 September 2010
Show/Hide Abstract | Cited by 1 | PDF Full-text (385 KB) | HTML Full-text | XML Full-text
abstract graphic

by ,  and
Pharmaceuticals 2010, 3(6), 1711-1728; doi:10.3390/ph3061711
Received: 21 April 2010; in revised form: 4 May 2010 / Accepted: 14 May 2010 / Published: 26 May 2010
Show/Hide Abstract | Cited by 20 | PDF Full-text (560 KB) | HTML Full-text | XML Full-text

by , , , , ,  and
Pharmaceuticals 2009, 2(3), 184-193; doi:10.3390/ph2030184
Received: 9 October 2009; in revised form: 9 November 2009 / Accepted: 1 December 2009 / Published: 15 December 2009
Show/Hide Abstract | Cited by 2 | PDF Full-text (174 KB) | HTML Full-text | XML Full-text

Last update: 7 August 2014

Pharmaceuticals EISSN 1424-8247 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert